-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UOGHXfiYN5XAvGhDCnQxZGlT+A3y9QduEpoGBSFg+LmBoj84mCdKB1bwnsA+HgQw a9kKBlGUKtwbit4fNK4+Uw== 0001013594-06-000522.txt : 20060928 0001013594-06-000522.hdr.sgml : 20060928 20060928172320 ACCESSION NUMBER: 0001013594-06-000522 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060928 DATE AS OF CHANGE: 20060928 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48781 FILM NUMBER: 061114856 BUSINESS ADDRESS: STREET 1: 11 STUDEBAKER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495957200 MAIL ADDRESS: STREET 1: 11 STUDEBAKER CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 222140975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 SC 13D/A 1 endologix13da-092706.htm SEPTEMBER 27, 2006

 


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

(Amendment No.3)*

Endologix, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

29266S106

(CUSIP Number)

Martin D. Sklar, Esq.

Kleinberg, Kaplan, Wolff & Cohen, P.C.

551 Fifth Avenue, New York, New York 10176

Tel: (212) 986-6000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

September 21, 2006

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box o.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 



 

 

 

1.

NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. ABOVE PERSONS (ENTITIES ONLY)

 

Elliott Associates, L.P.

 

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)    x

 

(b)    o

 

 

3.

SEC USE ONLY

 

 

4.

SOURCE OF FUNDS*

 

WC

 

 

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)    o

 

 

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

 

 

7.

SOLE VOTING POWER

 

2,055,999

 

 

8.

SHARED VOTING POWER

 

0

 

 

9.

SOLE DISPOSITIVE POWER

 

2,055,999

 

 

10.

SHARED DISPOSITIVE POWER

 

0

 

 

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,055,999

 

 

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)

 

EXCLUDES CERTAIN SHARES*    o

 

 

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.8%

 

 

14.

TYPE OF REPORTING PERSON*

 

PN

 

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 



 

 

1.

NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Elliott International, L.P.

 

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)    x

 

(b)    o

 

 

3.

SEC USE ONLY

 

 

4.

SOURCE OF FUNDS*

 

WC

 

 

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)    o

 

 

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Cayman Islands, British West Indies

 

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

 

 

7.

SOLE VOTING POWER

 

0

 

 

8.

SHARED VOTING POWER

 

3,084,001

 

 

9.

SOLE DISPOSITIVE POWER

 

0

 

 

10.

SHARED DISPOSITIVE POWER

 

3,084,001

 

 

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,084,001

 

 

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)

 

EXCLUDES CERTAIN SHARES*    o

 

 

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

7.2%

 

 

14.

TYPE OF REPORTING PERSON*

 

PN

 

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 



 

 

1.

NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Elliott International Capital Advisors Inc.

 

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)    x

 

(b)    o

 

 

3.

SEC USE ONLY

 

 

4.

SOURCE OF FUNDS*

 

OO

 

 

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)    o

 

 

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

 

 

7.

SOLE VOTING POWER

 

0

 

 

8.

SHARED VOTING POWER

 

3,084,001

 

 

9.

SOLE DISPOSITIVE POWER

 

0

 

 

10.

SHARED DISPOSITIVE POWER

 

3,084,001

 

 

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,084,001

 

 

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)

 

EXCLUDES CERTAIN SHARES*    o

 

 

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

7.2%

 

 

14.

TYPE OF REPORTING PERSON*

 

CO

 

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 



 

 

This statement is filed with respect to the shares of the common stock, $0.001 par value (the “Common Stock”), of Endologix, Inc. (the “Issuer”), beneficially owned by Elliott Associates, L.P. and its wholly-owned subsidiaries (collectively, “Elliott”), Elliott International, L.P. (“Elliott International”) and Elliott International Capital Advisors Inc. (“EICA”)(collectively, the “Reporting Persons”) as of September 21, 2006 and amends and supplements the Schedule 13D filed on April 7, 2006, as previously amended (collectively, the “Schedule 13D”). Except as set forth herein, the Schedule 13D is unmodified.

 

 

ITEM 3.

Source and Amount of Funds or Other Consideration.

 

 

Elliott Working Capital                         $9,755,208

 

 

Elliott International Working Capital   $14,632,823

 

 

ITEM 4.

Purpose of Transaction.

 

 

Each of Elliott and Elliott International acquired the Common Stock beneficially owned by it in the ordinary course of its purchasing, selling and trading in securities. EICA has acted as investment manager to Elliott International in connection with Elliott International’s acquisition of beneficial ownership of Common Stock.

 

 

Depending upon market conditions and other factors that it may deem material, each of Elliott and Elliott International may purchase additional shares of Common Stock and/or related securities or may dispose of all or a portion of the Common Stock or related securities that it now beneficially owns or may hereafter acquire.

 

 

Elliott and Elliott International reserve the right to further discuss and/or meet with management and other shareholders and/or formulate plans or proposals regarding the Issuer or its securities, including, directly or through the Consultant (as defined in Item 6 below), exploring strategic alternatives to increase shareholder value. See Item 6.

 

 

ITEM 5.

Interest in Securities of the Issuer.

 

 

(a)  Elliott beneficially owns 2,055,999 shares of Common Stock, constituting 4.8% of all of the outstanding shares of Common Stock.

 

 

Elliott International and EICA beneficially own an aggregate of 3,084,001 shares of Common Stock, constituting 7.2% of all of the outstanding shares of Common Stock.

 

 

 

 

 



 

 

 

Collectively, Elliott, Elliott International and EICA beneficially own 5,140,000 shares of Common Stock constituting 12.1% of all of the outstanding shares of Common Stock.

 

 

(b)  Elliott has the power to vote or direct the vote of, and to dispose or direct the disposition of, the shares of Common Stock beneficially owned by it.

 

 

Elliott International has the shared power with EICA to vote or direct the vote of, and to dispose or direct the disposition of, the shares of Common Stock owned by Elliott International. Information regarding each of Elliott International and EICA is set forth in Item 2 of this Schedule 13D and is expressly incorporated by reference herein.

 

 

(c)  No transactions were effected by the Reporting Persons during the past sixty days.

 

 

(d)  No person other than Elliott has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by Elliott.

 

 

No person other than Elliott International and EICA has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by Elliott International and EICA.

 

 

(e)  Not applicable.

 

 

ITEM 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

 

Elliott Management Corporation (“EMC”), an affiliate of the Reporting Persons, entered into a Consulting Agreement, dated as of September 21, 2006, with CB Technology Ventures LLC (the “Consultant”), a Colorado limited liability company, whereby the Consultant will provide research and evaluate possible opportunities and methodologies for increasing or maximizing the value of the Reporting Persons’ Common Stock of the Issuer. Pursuant to this Consulting Agreement, the Consultant is to receive a retainer fee as well as additional compensation, if any, based upon an increase in value of the Common Stock of the Issuer during specified periods of time.

 

 

 

 



 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of its knowledge and belief, the undersigned each certifies that the information with respect to it set forth in this statement is true, complete and correct.

 

Dated:    September 28, 2006

 

ELLIOTT ASSOCIATES, L.P.

By: Elliott Capital Advisors, L.P., as General Partner

 

By: Braxton Associates, Inc., as General Partner

 

 

 

 

 

By:  /s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

 

ELLIOTT INTERNATIONAL, L.P.

By:Elliott International Capital Advisors Inc.,

 

as Attorney-in-Fact

 

 

 

 

 

By:  /s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

 

ELLIOTT INTERNATIONAL CAPITAL ADVISORS INC.

 

 

 

 

By:  /s/ Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----